Friday, March 29, 2019 9:57:58 PM
We must realize the importance of epigenetic change due to toxic meds and environmental factors.
The impact on our portfolio is much less important than the impact on our children and their children....
Caligoldenbear11 Thursday, March 28, 2019 9:29:13 PM
Re: Doc logic post# 220264 Post # 220319 of 220489
Hi Doc,
Thank you for your response. I’m glad you found it useful. I strongly believe the highly processed vegetable oils (corn, canola, soybean) are a major contributor to the explosion in chronic diseases today. And you are absolutely correct there is controversy surrounding coconut oil but I believe it’s mostly manufactured. The American Heart Association and more recently a Harvard professor of epidemiology recommended against coconut oil based on the outdated idea that all saturated fats are bad for heart health. The medium chain triglycerides in coconut oil is a type of saturated fat but chemically is quite different from the saturated fat in red meat. MCTs can be easily used by the body as fuel and very little is stored as body fat. It’s interesting to note that the AHA receives funding from Canola oil council and vegetable oil manufacturers. While there is no randomized controlled trials on coconut oil and heart disease, coconut oil and coconut products have long been used by indigenous people in different parts of Asia as food and medicine. I don’t believe heart disease was a major issue for them.
Regarding glyphosate, the many lawsuits against the maker of glyphosate is raising awareness about the toxicity of glyphosate. I believe I read somewhere the manufacturer knew about the cancer causing effects but deliberately hid the info. There was a recent report by the Environmental Working Group that found high amounts of glyphosate in oat and wheat products including oatmeal, granola bars, and even in children’s cereal. Buying organic will reduce exposure to glyphosate but does not guarantee no exposure since they found traces even in organic products. Farmers use glyphosate as a drying agent routinely during harvests of crops such as wheat, oats and even beans. Unfortunately, glyphosate is so prevalent in the environment that its effects will last for a long time into the future. You can even find glyphosate in drinking water and there is no dose that is safe. I think glyphosate is one of the most underrated causes of the cancer epidemic we have today. Oatmeal might have been a health food for our parents and grandparents, but I don’t believe it is anymore.
There is growing demand for holistic and integrative medicine because some people are getting tired of the “A pill for an ill” model. But there will always be a place for conventional medicine. Conventional medicine will always be the dominant and mainstream medicine thanks to BP. DCVax will hopefully revolutionize conventional cancer treatments and make it more effective and safer.
Best regards
https://investorshub.advfn.com/boards/read_msgs.aspx?board_id=3441&NextStart=220318&BatchSize=20
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM

